A phase 3 multicentre, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Ustekinumab in the treatment of adolescent subjects with moderate to severe plaque-type Psoriasis - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: A phase 3 multicentre, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Ustekinumab in the treatment of adolescent subjects with moderate to severe plaque-type Psoriasis

Funder
Cardiff & Vale University Health Board

Principal Investigator

Piguet, Vincent

Project Details

Net value award figure for Cardiff University: £2,818.00

Start date: 01/01/2014

End date: 31/03/2014

Our policy towards the use of cookies